Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

IRB

Showing results (731-740 of 778) with videos related to

Pageof 78
Sort By:
IRB|March 24, 2004
Should nonresponders dictate the use of placebos?Joseph P DeMarco
IRB|June 14, 2005
Just-in-time IRB review: capitalizing on scientific merit review to improve human subjects research complianceP Adam Kelly, Michael L Johnson
IRB|January 22, 2005
Quebec physicians' knowledge and opinions regarding substitute consent for decisionally incapacitated older adultsGina Bravo, Marie-France Dubois, Mariane Paquet, et al.
IRB|January 22, 2005
By any other name: the many iterations of "patient advocate" in clinical researchE Haavi Morreim
IRB|April 20, 2005
Consent forms and the therapeutic misconception: the example of gene transfer researchNancy M P King, Gail E Henderson, Larry R Churchill, et al.
IRB|April 20, 2005
The quality of informed consent in a clinical research study in ThailandChristine Pace, Ezekiel J Emanuel, Theshinee Chuenyam, et al.
IRB|March 1, 2008
Disclosure of information to potential subjects on research recruitment web sitesRobert Klitzman, Ilene Albala, Joseph Siragusa, et al.
IRB|February 2, 2008
How to make consent informed: possible lessons from TibetSuellen Miller, Phuoc V Le, Sienna Craig, et al.
IRB|January 24, 2006
What IRBs could learn from corporate boardsRichard S Saver
IRB|January 24, 2006
Vulnerable subjects and Canadian research governanceMark Wilson
Pageof 78

Showing results (731-740 of 778) with videos related to

Sort By:
Pageof 78
IRB|March 24, 2004
Should nonresponders dictate the use of placebos?Joseph P DeMarco
IRB|June 14, 2005
Just-in-time IRB review: capitalizing on scientific merit review to improve human subjects research complianceP Adam Kelly, Michael L Johnson
IRB|January 22, 2005
Quebec physicians' knowledge and opinions regarding substitute consent for decisionally incapacitated older adultsGina Bravo, Marie-France Dubois, Mariane Paquet, et al.
IRB|January 22, 2005
By any other name: the many iterations of "patient advocate" in clinical researchE Haavi Morreim
IRB|April 20, 2005
Consent forms and the therapeutic misconception: the example of gene transfer researchNancy M P King, Gail E Henderson, Larry R Churchill, et al.
IRB|April 20, 2005
The quality of informed consent in a clinical research study in ThailandChristine Pace, Ezekiel J Emanuel, Theshinee Chuenyam, et al.
IRB|March 1, 2008
Disclosure of information to potential subjects on research recruitment web sitesRobert Klitzman, Ilene Albala, Joseph Siragusa, et al.
IRB|February 2, 2008
How to make consent informed: possible lessons from TibetSuellen Miller, Phuoc V Le, Sienna Craig, et al.
IRB|January 24, 2006
What IRBs could learn from corporate boardsRichard S Saver
IRB|January 24, 2006
Vulnerable subjects and Canadian research governanceMark Wilson
Pageof 78